Home › Entities › academia › Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

Research article (European Journal of Nuclear Medicine and Molecular Imaging, 2022) · cited 104× · AI/ML
academia openalex:W4296164040
Press Enter · cited answer in seconds

Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

Summary

Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group is a scholarly article[1].

Key Facts

  • Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Retrieved May 24, 2026, from https://4ort.xyz/entity/clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re
MLA “Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re.
BibTeX @misc{4ortxyz_clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group}}, year = {2026}, url = {https://4ort.xyz/entity/clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group — https://4ort.xyz/entity/clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/clinical-dosimetric-and-reporting-considerations-for-y-90-glass-microspheres-in-hepatocellular-carcinoma-updated-2022-re · Last refreshed: